Security key
71880W402
- Security type / class
- Equity / COM
- Total 13F shares
- 130,502
- Total 13F value
- $89,042
- Share change
- -356,432
- SEC-reported price per share
- $0.68
- Number of holders
- 9
- Value change
- -$273,031
- Number of buys
- 3
- Number of sells
- 6
Report period
Q1 2024
Institutions
9
Top holders
9
PHIO full security history
Ownership snapshot
Full 13F holder table
Phio Pharmaceuticals Corp. SEC filings
Phio Pharmaceuticals Corp. company facts
Broader feeds
Ownership snapshot
Top reported holders of PHIO - PHIO PHARMACEUTICALS CORP - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Gerrit Dispersyn
Disclosed value leader
Gerrit Dispersyn
Comparable rows
0/15
Latest evidence
01 Mar 2024
3/4/5
13F
Highest disclosed value: $320,614
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Gerrit Dispersyn has the largest disclosed position value at $320.6K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Gerrit Dispersyn's linked filing trail.
Disclosed position value
Top 5
Gerrit Dispersyn
$320.6K
SABBY MANAGEMENT, LLC
$131.2K
Anson Funds Management LP
$119.6K
H. Paul Dorman
$30.8K
CITADEL ADVISORS LLC
$24.2K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Gerrit Dispersyn |
3/4/5
President & CEO, Director
|
—
denominator unverified
|
$320,614
212,327 shares
|
— | 01 Mar 2022 |
| SABBY MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$131,247
172,693 shares
|
— | 31 Dec 2023 |
| Anson Funds Management LP |
13F
Company
|
—
denominator unverified
|
$119,643
157,425 shares
|
— | 31 Dec 2023 |
| H. Paul Dorman |
3/4/5
Director
|
—
denominator unverified
|
$30,759
20,370 shares
|
— | 15 Feb 2022 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$24,201
31,843 shares
|
— | 31 Dec 2023 |
| BANK OF MONTREAL /CAN/ |
13F
Company
|
—
denominator unverified
|
$19,000
20,000 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
9
Shares
130,502
Rows available
9
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
9
Q1 2024 holders
9
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|